not vested
Ekso Bionics Holdings Announces Uplisting to Nasdaq Capital Market and Pricing of $15 Million Offering of Common StockRICHMOND, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced approval to list its common stock on the Nasdaq Capital Market.
The Company’s common stock will begin trading under the symbol “EKSO” at the opening of trading on August 9, 2016.
The Company also announced today the pricing of the previously announced underwritten public offering of 3,750,000 shares of its common stock to new and existing investors at a price to the public of $4.00 per share.
The offering is expected to close on or about August 12, 2016, subject to customary closing conditions.
The Company expects to receive net proceeds of approximately $13.7 million from the sale of common stock in the offering, after deducting the underwriting discounts and estimated offering expenses payable by it.
The Company intends to use the net proceeds from this offering for its operations, including, but not limited to, increasing its investments
(i) in its clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market;
(ii) in its research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use, as well as for working capital and other general corporate purposes.
Source: Yahoo Finance
http://finance.yahoo.com/news/ekso-bion ... 00133.html